Canopy Rivers Inc., the venture capital arm of the world’s most valuable cannabis company, Canopy Growth Corp., is investing more than US$3 million in Headset, a Salveo Capital portfolio company. Headset is the first direct U.S. investment for Toronto-based Canopy Rivers.
Read MorePlenty of firms are angling to get into the cannabis business without actually touching the plant. Though most of the venture-backed ancillary cannabis businesses that focus on technology are based on the West Coast, the Chicago area is home to a few others with different specialties - input provided by Michael Gruber, a managing partner at Salveo Capital.
Read MoreSalveo Capital portfolio company, TILT, announced a new addition to its “family” of businesses Thursday. The company said it agreed to acquire Jupiter Research for $210 million. Jupiter is engaged in developing inhalation and vaporization technology.
Read MoreSalveo Capital and Privateer Holdings, among others, are already investing in hemp-related businesses while start-ups grow as quickly as possible through M&A as a new industry in CBD and other products scales up.
Read MoreMichael Gruber, a managing partner at Salveo Capital, a cannabis-focused investment firm, said the Altria/Cronos deal could open the floodgates for similar deals, particularly as the U.S. market inches toward federal legalization.
Read MoreSalveo Capital portfolio company, TILT Holdings Inc. (CSE:TILT), a vertically-integrated infrastructure and technology cannabis company, officially began trading on the Canadian Securities Exchange.
Read MoreSalveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced it has acquired a minority equity interest in Ascend Wellness (“Ascend”), a vertically integrated multi-state operator in the cannabis industry.
Read MoreSalveo Capital portfolio company, TILT, announced it has acquired two leading cannabis companies to expand its capabilities in the cultivation and logistics spaces. This announcement is the latest in a series of moves to expand TILT’s offerings for cannabis businesses and consumers.
Read MoreSalveo Capital portfolio company, Front Range Biosciences, today announced that it signed a lease with Memorial Florists and Greenhouses Inc. for a Clean Stock® hemp nursery in Appleton, Wisconsin.
Read More“Harborside, one of the most iconic and well-known brands in the cannabis industry, with an extensive and loyal customer base, is poised for significant expansion in the California market,” said Michael Gruber and Jeffrey Howard, Managing Partners at Salveo Capital.
Read MoreSalveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced that it has completed an investment in Harborside, the iconic California-based vertically integrated cannabis company.
Read MoreMichael Gruber and Jeffrey Howard, managing partners of Salveo Capital, a cannabis investment firm, also joined in the merriment but sounded a cautious note regarding Sessions’ replacement.
Read MoreMergers & Acquisitions asked Michael Gruber, managing partner at Salveo Capital, to share his thoughts on how the mid-term elections will affect M&A and the cannabis sector.
Read MoreThe Northbrook, Ill.-based firm has avoided investments in companies that touch the plant, but recent regulatory advances in the industry have encouraged the firm to reconsider its approach.
Read MoreCanada has joined Uruguay to become the second country in the world to legalize pot. What does the new federal law mean for private equity? TBD. Marijuana legalization up north did give me a reason to check in with Salveo Capital – which invests not in growers but in underlying services like testing technology for cannabis labs – to hear their two cents.
Read MoreTo get a handle on who's cutting early-stage deals in the fledgling industry, Business Insider pulled data from PitchBook and reached out to the top venture-capital firms (including Salveo Capital) in the industry.
Read MoreChicago-based cannabis investment firm Salveo Capital has participated in a $10 million Series A round for Front Range Biosciences, a Colorado-headquartered company focused on tissue-culture propagation of high-value crops.
Read MoreLeading agricultural biotech company (and a Salveo Capital portfolio company) closes largest ever U.S. cannabis biotech funding round.
Read MoreSalveo Capital, an alternative investment firm specializing in the legalized cannabis space, today announced the formation of its Advisory Board comprised of a select group of professionals who will provide guidance to the firm on various strategic matters.
Read MoreAs the legalized pot industry continues to see explosive growth, Salveo Capital is moving quickly to capture the one segment of the market it has deemed underserved.
Read More
